Cancer is a multifactorial pathology and it represents the second leading cause of death
worldwide. In the recent years, numerous studies highlighted the dual role of the gut …

Bacteria present in probiotics, particularly the common Lactobacillus and Bifidobacterium
microbes, have been found to induce anti-cancer action by enhancing cancer cell apoptosis …

Lactobacillus rhamnosus GG (LGG) was the first strain belonging to the genus Lactobacillus
to be patented in 1989 thanks to its ability to survive and to proliferate at gastric acid pH and …

Intestinal diseases, such as inflammatory bowel diseases (IBDs) and colorectal cancer
(CRC) generally characterized by clinical symptoms, including malabsorption, intestinal …

Background Gut microbiota modulation has been demonstrated to be effective in protecting
patients against detrimental effects of anti-cancer therapies, as well as to improve the …

Lactobacillus casei, Lactobacillus paracasei, and Lactobacillus rhamnosus are
phenotypically and genotypically closely related, and together comprise the L. casei group …

Cancer is the second leading cause of death in the western world. In the era of precision
medicine, a significant number of cancer patients can be cured with several anti-cancer …

The main objective of this study was to isolate lactic acid bacteria from kefir grains and
investigate their probiotic potential. In this study, 48 bacterial strains were isolated from kefir …

The beneficial effects of two potential probiotic lactobacillus strains, namely Lactobacillus
pentosus B281 and L. plantarum B282 were examined and the mechanisms of action were …

The gut microbiota (GM) has been shown to be closely associated with the development of
colorectal cancer (CRC). However, the involvement of GM is CRC has mainly been …